["... and now about the costs!"].
作者信息
Rohde Detlef
出版信息
Aktuelle Urol. 2008 Jan;39(1):2 p preceding table of contents.
PMID:18303603
Abstract
摘要
相似文献
1
["... and now about the costs!"].["……现在谈谈成本！"]
Aktuelle Urol. 2008 Jan;39(1):2 p preceding table of contents.
2
The Costly War Against Cancer Treatment: The Example of Metastatic Renal Cell Carcinoma in Portugal.
Acta Med Port. 2018 Aug 31;31(7-8):373-375. doi: 10.20344/amp.9969.
3
Advanced renal cell carcinoma in Australia, 2015: what should we do?
Asia Pac J Clin Oncol. 2014 Dec;10(4):285-8. doi: 10.1111/ajco.12314.
4
The Authors Respond.
J Manag Care Spec Pharm. 2015 Sep;21(9):844.
5
Welcome clinical leadership at NICE.欢迎英国国家卫生与临床优化研究所的临床领导力。
Lancet. 2008 Aug 23;372(9639):601. doi: 10.1016/S0140-6736(08)61249-0.
6
Treatment patterns and costs for metastatic renal cell carcinoma patients with private insurance in the United States.美国拥有私人保险的转移性肾细胞癌患者的治疗模式与费用
Clin Genitourin Cancer. 2015 Apr;13(2):e93-100. doi: 10.1016/j.clgc.2014.08.013. Epub 2014 Sep 28.
7
The Authors Respond.
J Manag Care Spec Pharm. 2015 Sep;21(9):836-40.
8
The National Institute of Health and Clinical Excellence rejects new treatments for renal cell cancer: Cinderella's invitation is cancelled.
BJU Int. 2008 Dec;102(11):1491-2. doi: 10.1111/j.1464-410X.2008.08164.x. Epub 2008 Oct 24.
9
[Ⅳ. Current Economic Issues in Treatment for Metastatic Renal Cell Carcinoma].
Gan To Kagaku Ryoho. 2019 Jan;46(1):50-53.
10
The role of socioeconomic status in renal cell carcinoma.社会经济地位在肾细胞癌中的作用。
Urol Oncol. 2012 Jan-Feb;30(1):89-94. doi: 10.1016/j.urolonc.2011.08.003. Epub 2011 Sep 9.
Zotero 插件